Document is current
Any future updates will be listed below
-
Authors
Shimony, Shai http://orcid.org/0000-0001-7245-9652
Garcia, Jacqueline S. http://orcid.org/0000-0003-2118-6302
Keating, Julia
Chen, Evan C.
Luskin, Marlise R. http://orcid.org/0000-0002-5781-4529
Stahl, Maximilian
Neuberg, Donna S. http://orcid.org/0000-0003-2566-3145
DeAngelo, Daniel J. http://orcid.org/0000-0001-7865-2306
Stone, Richard M. http://orcid.org/0000-0002-7526-2633
Lindsley, R. Coleman http://orcid.org/0000-0001-9822-806X
- License Information
-
More Information
Article History
Received: 31 January 2024
Revised: 6 March 2024
Accepted: 11 March 2024
First Online: 27 March 2024
Competing interests
: SS and JK have no COI to declare. JSG reports consultancy for Abvie, Astellas, Astra-Zeneca; Research funding from Abbvie, NewWave Therapeutics, Pfizer, Prelude; Member on Board of Directors in Abbvie, Genentech, Servier. ECC reports consultancy for Rigel Pharmaceuticals and research funding from Abbvie. MRL reports consultancy for Novartis, Pfizer, and Jazz; Research funding from Novartis and Abbvie. MS reports consultancy and serves as a member of the board of directors in Kymera, GSK and Rigel Pharmaceuticals; DSN reports equity holder in Madrigal Pharmaceuticals. DJD reports consultancy for Amgen, Autolus, Blueprint, Gilead, Incyte, Jazz, Kite, Novartis, Pfizer, Servier, and Takeda; received research funding from Abbvie, Novartis, Blueprint and Glycomimetrics. RMS reports consultancy for Abbvie, CTI Biopharma, GSK, Hermavant, Ligand Pharma, Lava Therapeutics, Amgen, AvenCell, BerGenBio, Cellularity, Jazz, Kura One, Rigel Pharmaecuticals. Serves on safety committee members in Aptevo, Epizyme, Takeda, and Syntrix. RCL reports consultancy for Takeda Pharmaceuticals, Bluebird Bio, Qiagen, Sarepta Therapeutics, Verve Therapeutics, Jazz Pharmaceuticals and Vertex Pharmaceuticals.
